Can growth hormone ease knee pain? new pilot study aims to find out

NCT ID NCT07036003

Recruiting now Symptom relief Sponsor: Dr. David Wasserstein Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests whether people with knee osteoarthritis can stick to a daily routine of self-injecting recombinant human growth hormone (rHGH) for six weeks. Researchers will track how well participants follow the regimen, along with changes in knee strength, range of motion, and pain. The goal is to see if this approach is practical enough to study further for easing osteoarthritis symptoms.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS (KNEE OA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

osteoarthritis, knee

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KNEE OSTEOARTHRITIS (KNEE OA) KNEE OSTEOARTHRITIS (OA)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Sunnybrook Health Sciences Centre
RECRUITING

Toronto, Ontario, M4N 3M5, Canada

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact